Wednesday, May 8
Session Description: Here, ever recurring questions and hot topics in the clinical management of patients with primary electrical disease are discussed.
Session Description: The session intends to describe the influence of age and gender on the incidence, course and treatment results of cardiac arrhythmias.
Thursday, May 9
Session Description: Be honest - how often are you tempted to ignore the 12 lead and go straight for the intracardiac? However you look at it, the ECG is key to EP. Come hear masters in the field of ECG-ology remind you of how many hidden gems there are if you really look attentively at the surface ECG.
Session Description: Need a refresher on diagnostic maneuvers? New to EP, or just a lover of intracardiac electrograms? This session will highlight maneuvers used in common narrow and wide complex rhythms. It will be of interest to all, no matter what your level of EP expertise.
Session Description: This session will provide an analysis of what is known about syncope, mechanisms and treatments. Knowledge gaps will be identified as well as potential areas for future investigation and treatment strategies.
Session Description: In this session, two experts in the field are discussion the chances and limits of the newly introduced technique of ablation for Brugada syndrome.
Session Description: To educate the audience about the potential benefits of LAA occlusion in patients with persistent/permanent AF relative to OAC.
MP11. Epidemiology of AF Revisited
Session Description: The session aims at clarifying aspects of the etiology of AF and its clinical significance in different patients' populations
S-044. Critical Management Issues in Cardiomyopathy Patients: From Quality of Life to SCD Prevention
Session Description: This session will explore clinical management issues in cardiomyopathy/SCD patients from determining candidates for device therapy, to discussion of end of life issues.
Session Description: Patients with comorbidities like renal disease, CAD or after cryptogenic stroke as well as patients in special situations like e.g. ablation are difficult to manage in terms of stroke prevention. Come and find out how renowned experts in the field try to solve unsolvable clinical settings.
Session Description: Secondary atrial fibrillation (AF) is a common phenomenon, occurring especially postoperatively, after myocardial infarction or during an acute illness. Learn about risks of late recurrence of AF after a secondary AF episode, specific clinical features and echocardiographic data which could help identify high-risk patients for late recurrence of AF. Prepare strategies for further follow-up after secondary AF episodes. Attendees will review the more recent information available on secondary AF and improve everyday practice. A Joint Session presented by the Canadian Cardiovascular Society (CCS).
Session Description: The session will showcase the latest research on AF epidemiology in India and atrial arrhythmia management in valvular heart disease with a focus on rheumatic heart disease, and the outcomes of catheter ablation. A Joint Session presented by the Indian Heart Rhythm Society (IHRS).
Friday, May 10
MP13. Oral Anticoagulation and LAA Occluder - Effects, Side-effects and Open Questions
Session Description: This sessions deals with the management of oral anticoagulation and LAA occluder in the setting of AF.
Session Description: This session is designed to familiarize attendees with a variety of adjunctive mapping techniques which can be used during AF ablations, and when and how to use them.
S-060. How to Use Best Diagnostic Maneuvers in Differentiating Supraventricular and Ventricular Tachycardia
Session Description: Diagnostic maneuvers are critical in differentiating types of supraventricular tachycardia, differentiating supraventricular tachycardia from ventricular tachycardia and vise versa. This session provides the clinical pearls of how to use programmed electrical stimulation to build up your diagnostic skills and approach in the EP lab to facilitate pulmonary vein isolation, supraventricular and ventricular tachycardia ablation.
Session Description: This session aims at describing difficult decision-taking for SCD prevention in inherited arrhythmia syndromes and cardiomyopathies.
Session Description: This session addresses the non-invasive, pharmacological treatment options in cardiac arrhythmias and heart failure patients with an overview over outcome results and side effects.
Session Description: This session aims at showing a master at his work - complex SVT cases are presented to an outstanding, experienced EP person, who will discuss his thoughts and diagnostic steps to understand the pathophysiological mechanisms of the presented arrhythmias.
MP12. Mapping AF - What ECG Recordings Can Tell
Session Description: The session aims at exploring all aspects of AF ECG recordings obtained from surface ECG, endocardial and epicardial
Session Description: Are you confident as to when and how imaging can maximize the success of your EP procedures? This session will integrate the knowledge of multiple imaging modalities including multi-channel electrocardiography, echocardiography, cardiac CT, cardiac MRI and cardiac nuclear imaging to guide diagnosis and management of ventricular arrhythmia, and to facilitate catheter ablation.
Session Description: To highlight cases of SVT where either underlying disease complicated management of SVT or where SVT resulted in adverse outcomes.
Saturday, May 11
Session Description: In this session the risks and benefits of exercise will be discussed with specific regard to patients with Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Atrial fibrillation and Wolf Parkinson White syndrome.